Kate Collins
Research Scientist at the Nathan Kline Institute for Psychiatric Research and Assistant Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai
Data updated
Research Footprint
Kate Collins appears in 5 tracked papers (2012–2021), most studied alongside Ketamine, across Depressive Disorders, Major Depressive Disorder (MDD) and Neuroimaging & Brain Measures.
Most-cited paper: Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression (783 citations).
Frequent co-authors: James Murrough, Dennis Charney and Daniel Iosifescu.
Background & Research
Kate Collins, Ph.D., M.S.W., is a research scientist at the Nathan Kline Institute for Psychiatric Research and an Assistant Clinical Professor in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai. Her training spans social work and neuroscience, and her research focuses on clinical trials and functional MRI studies in mood and anxiety disorders, including ketamine-based interventions.
Key Impact
She is a clinical neuroscience researcher on ketamine trials and neuroimaging studies in PTSD and major depression, helping characterize rapid-acting antidepressant mechanisms.
Collaboration Network
9 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Kate Collins is associated with.